DELAWARE
|
13-4306188
|
|
(State or Other
Jurisdiction of
Incorporation or
Organization)
|
I.R.S. Employer
Identification No.
|
|
2275 Research Blvd., Suite 500
Rockville, Maryland 20850
|
||
(Address of Principal Executive Offices, Zip Code)
|
||
(301) 840-3888
|
||
(Registrant’s Telephone Number, Including Area Code)
|
Large accelerated filer o
|
Accelerated filer x
|
Non-accelerated filer o
|
Smaller reporting company o
|
Item 1. Financial Statements (unaudited)
|
1
|
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
11
|
Item 3. Quantitative and Qualitative Disclosures About Market Risk
|
18
|
Item 4. Controls and Procedures
|
18
|
PART II OTHER INFORMATION
|
|
Item 1. Legal Proceedings
|
19
|
Item 1A. Risk Factors
|
19
|
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
|
19
|
Item 3. Defaults Upon Senior Securities
|
19
|
Item 4. Mine Safety Disclosures
|
19
|
Item 5. Other Information
|
19
|
Item 6. Exhibits
|
19
|
Signatures
|
20
|
June 30,
2013
|
March 31,
2013
|
|||||||
ASSETS
|
||||||||
Current Assets:
|
||||||||
Cash and cash equivalents
|
$
|
80,934
|
$
|
79,050
|
||||
Restricted cash
|
63,108
|
68,410
|
||||||
Accounts receivable, net of allowance of $5,785 and $7,515, respectively
|
24,651
|
30,183
|
||||||
Inventories
|
79,894
|
87,707
|
||||||
Due from related parties
|
3,020
|
2,696
|
||||||
Income tax receivable
|
6
|
5
|
Prepaid expenses and other current assets
|
22,520
|
18,404
|
||||||
Total current assets
|
274,133
|
286,455
|
||||||
Property, plant and equipment, net
|
129,934
|
130,121
|
||||||
Land use rights, net
|
10,923
|
10,829
|
||||||
Intangible assets, net
|
4,123
|
4,135
|
||||||
Restricted cash
|
48,557
|
39,883
|
||||||
Due from related parties
|
2,908
|
2,981
|
||||||
Other assets
|
2,938
|
1,740
|
||||||
TOTAL ASSETS
|
$
|
473,516
|
$
|
476,144
|
||||
LIABILITIES AND EQUITY
|
||||||||
Current Liabilities:
|
||||||||
Short-term debt
|
$
|
116,400
|
$
|
127,449
|
||||
Long-term debt due within one year
|
90,823
|
82,663
|
||||||
Accounts payable
|
48,455
|
48,717
|
||||||
Due to related parties
|
1,629
|
1,862
|
||||||
Advances from customers
|
9,878
|
12,982
|
||||||
Other current liabilities
|
42,858
|
52,788
|
||||||
Total current liabilities
|
310,043
|
326,461
|
||||||
Long-term debt
|
110,414
|
102,164
|
||||||
Deferred revenue
|
4,371
|
4,402
|
||||||
Capital lease obligations
|
7,938
|
7,848
|
||||||
Other long-term liabilities
|
6,215
|
6,062
|
||||||
Total liabilities
|
438,981
|
446,937
|
||||||
Commitments and Contingencies
|
||||||||
Equity:
|
||||||||
Common stockholders’ equity:
|
||||||||
Common stock, $.0001 par value: 250,000 authorized; 57,301 and 57,301 issued and
outstanding at June 30, 2013 and March 31, 2013,
respectively
|
6
|
6
|
||||||
Additional paid-in capital
|
135,440
|
135,440
|
||||||
Accumulated deficit
|
(130,733
|
)
|
(135,508
|
)
|
||||
Accumulated other comprehensive income
|
29,380
|
28,828
|
||||||
Total common stockholders’ equity
|
34,093
|
28,766
|
||||||
Noncontrolling interest
|
442
|
441
|
||||||
Total equity
|
34,535
|
29,207
|
||||||
TOTAL LIABILITIES AND EQUITY
|
$
|
473,516
|
$
|
476,144
|
Three Months
Ended June 30,
|
||||||||
2013
|
2012
|
|||||||
Net sales
|
$
|
82,205
|
$
|
53,586
|
||||
Cost of sales
|
46,124
|
36,285
|
||||||
Gross profit
|
36,081
|
17,301
|
||||||
Selling and distribution expenses
|
14,771
|
13,117
|
||||||
Advertising and promotion expenses
|
8,476
|
6,804
|
||||||
General and administrative expenses
|
6,452
|
7,857
|
||||||
Gain on disposal and liquidation of subsidiaries
|
367
|
420
|
||||||
Government subsidies
|
165
|
885
|
||||||
Income (loss) from operations
|
6,914
|
(9,172
|
)
|
|||||
Interest expense
|
3,887
|
3,556
|
||||||
Interest income
|
1,087
|
487
|
||||||
Other income (expense), net
|
741
|
(438
|
)
|
|||||
Income (loss) before income tax expense (benefit)
|
4,855
|
(12,679
|
)
|
|||||
Income tax expense (benefit)
|
79
|
(2,903
|
)
|
|||||
Net income (loss)
|
4,776
|
(9,776
|
)
|
|||||
Net income (loss) attributable to the noncontrolling interest
|
1
|
(77
|
)
|
|||||
Net income (loss) attributable to common stockholders
|
$
|
4,775
|
$
|
(9,699
|
)
|
|||
Weighted average common stock outstanding – basic
|
57,301
|
57,301
|
||||||
Earnings (loss) per share – basic
|
$
|
0.08
|
$
|
(0.17
|
)
|
Three Months Ended June 30,
|
||||||||
2013
|
2012
|
|||||||
Net income (loss)
|
$
|
4,776
|
$
|
(9,776
|
)
|
|||
Other comprehensive income (loss), net of tax
|
||||||||
Currency translation adjustment
|
552
|
(578
|
)
|
|||||
Reclassification of currency translation adjustments realized
upon disposal and liquidation of subsidiaries
|
0
|
(420
|
)
|
|||||
Other comprehensive income (loss)
|
552
|
(998
|
)
|
|||||
Comprehensive income (loss)
|
5,328
|
(10,774
|
)
|
|||||
Less: Comprehensive income (loss) attributable to noncontrolling interest
|
1
|
(79
|
)
|
|||||
Comprehensive income (loss) attributable to common stockholders
|
$
|
5,327
|
$
|
(10,695
|
)
|
Synutra International, Inc. Stockholders’ Equity
|
||||||||||||||||||||||||||||
Common Stock
|
||||||||||||||||||||||||||||
Shares
|
Amount
|
Additional
paid-in
capital
|
Retained
earnings (accumulated
deficit)
|
Accumulated
other comprehensive
income
|
Noncontrolling
Interest
|
Total
equity
|
||||||||||||||||||||||
Balance, March 31, 2012
|
57,301
|
$
|
6
|
$
|
135,440
|
$
|
(71,620
|
)
|
$
|
32,201
|
$
|
1,065
|
$
|
97,092
|
||||||||||||||
Net loss
|
0
|
0
|
0
|
(9,699
|
)
|
0
|
(77
|
)
|
(9,776
|
)
|
||||||||||||||||||
Other comprehensive
income, net of
tax of nil
|
0
|
0
|
0
|
0
|
(996
|
)
|
(2
|
)
|
(998
|
)
|
||||||||||||||||||
Other
|
0
|
0
|
0
|
0
|
0
|
39
|
39
|
|||||||||||||||||||||
Balance, June 30, 2012
|
57,301
|
$
|
6
|
$
|
135,440
|
$
|
(81,319
|
)
|
$
|
31,205
|
$
|
1,025
|
$
|
86,357
|
||||||||||||||
Balance, March 31, 2013
|
57,301
|
$
|
6
|
$
|
135,440
|
$
|
(135,508
|
)
|
$
|
28,828
|
$
|
441
|
$
|
29,207
|
||||||||||||||
Net loss
|
0
|
0
|
0
|
4,775
|
0
|
1
|
4,776
|
|||||||||||||||||||||
Other comprehensive
income, net of
tax of nil
|
0
|
0
|
0
|
0
|
552
|
0
|
552
|
|||||||||||||||||||||
Balance, June 30, 2013
|
57,301
|
$
|
6
|
$
|
135,440
|
$
|
(130,733
|
)
|
$
|
29,380
|
$
|
442
|
$
|
34,535
|
Three Months Ended June 30,
|
||||||||
2013
|
2012
|
|||||||
Operating activities:
|
||||||||
Net income (loss)
|
$
|
4,776
|
$
|
(9,776
|
)
|
|||
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
|
||||||||
Depreciation and amortization
|
3,495
|
3,321
|
||||||
Bad debt expense
|
(413
|
)
|
922
|
|||||
Deferred income tax
|
0
|
7
|
||||||
Gain on disposal and liquidation of subsidiaries
|
(367
|
)
|
(420
|
)
|
||||
Other
|
46
|
31
|
||||||
Changes in assets and liabilities:
|
||||||||
Accounts receivable
|
6,333
|
1,310
|
||||||
Inventories
|
9,066
|
(11,329
|
)
|
|||||
Due from related parties
|
(358
|
)
|
192
|
|||||
Other assets
|
(3,534
|
)
|
(7,791
|
)
|
||||
Accounts payable
|
(1,492
|
)
|
(11,054
|
)
|
||||
Due to related parties
|
(228
|
)
|
183
|
|||||
Advances from customers
|
(3,279
|
)
|
82
|
|||||
Income tax receivable
|
1
|
(3,447
|
)
|
|||||
Other liabilities
|
(10,710
|
)
|
(4,648
|
)
|
||||
Net cash provided by (used in) operating activities
|
3,336
|
(42,417
|
)
|
|||||
Investing activities:
|
||||||||
Acquisition of property, plant and equipment
|
(2,284
|
)
|
(2,894
|
)
|
||||
Change in restricted cash
|
(1,976
|
)
|
(1,935
|
)
|
||||
Proceeds from assets disposal
|
106
|
1,552
|
||||||
Proceeds from disposal of subsidiaries
|
358
|
0
|
||||||
Net cash provided by (used in) investing activities
|
(3,796
|
)
|
(3,277
|
)
|
||||
Financing activities:
|
||||||||
Proceeds from short-term debt
|
42,297
|
76,446
|
||||||
Repayment of short-term debt
|
(54,730
|
)
|
(34,471
|
)
|
||||
Proceeds from long-term debt
|
40,776
|
39,103
|
||||||
Repayment of long-term debt
|
(26,347
|
)
|
(31,688
|
)
|
||||
Payment on capital lease obligations
|
(104
|
)
|
(262
|
)
|
||||
Net cash provided by (used in) financing activities
|
1,892
|
49,128
|
||||||
Effect of exchange rate changes on cash and cash equivalents
|
452
|
(144
|
)
|
|||||
Net change in cash and cash equivalents
|
1,884
|
3,290
|
||||||
Cash and cash equivalents, beginning of period
|
79,050
|
64,793
|
||||||
Cash and cash equivalents, end of period
|
$
|
80,934
|
$
|
68,083
|
||||
Supplemental cash flow information:
|
||||||||
Interest paid
|
3,782
|
3,386
|
||||||
Income tax paid
|
75
|
532
|
||||||
Non-cash investing and financing activities:
|
||||||||
Purchase of property, plant and equipment by payable
|
7,228
|
12,221
|
1.
|
ORGANIZATION AND PRINCIPAL ACTIVITIES
|
2.
|
BASIS OF PRESENTATION
|
·
|
The Company believes that the loss from operations for the year ended March 31, 2013 is primarily attributable to the short term effect of a substantial increase in the retail price of the Company’s powdered formula products beginning April 1, 2012 and management’s rationalization of the Company's sales channel which was initiated in September 2012 and was substantially completed by March 2013. The Company managed to reverse the trend contributing to losses incurred in first half of fiscal 2013, with breakeven results from operations in the third quarter of fiscal 2013, and income from operations in the fourth quarter of fiscal 2013 and first quarter of fiscal 2014.
|
·
|
In addition, the Company had positive cash flows from operations for the second half of fiscal 2013 of $41.8 million and for first quarter of fiscal 2014 of $3.3 million. The Company believes that its cash flows from operations will be sufficiently positive for next twelve months to satisfy its obligations when they fall due.
|
·
|
As of June 30, 2013, the Company had unused credit facility of $17.1 million which could be used when purchase of materials is initiated and the purchased inventory is used as pledge. The facility is not unconditionally committed as the bank may refuse to fund if there is material adverse change to the Company’s operations. However, for normal operational needs, it provides a backup source of liquidity.
|
·
|
In July 2013, the Company had repaid short-term bank loans of $22.8 million, had borrowed short-term bank loans of $22.3 million and long-term bank loans of $3.2 million.
|
3.
|
INVENTORIES
|
(In thousands)
|
June 30,
2013
|
March 31,
2013
|
||||||
Raw materials
|
$
|
47,043
|
$
|
56,607
|
||||
Work-in-progress
|
19,973
|
17,023
|
||||||
Finished goods
|
12,878
|
14,077
|
||||||
Total
|
$
|
79,894
|
$
|
87,707
|
4.
|
RELATED PARTIES AND RELATED PARTY TRANSACTIONS
|
A.
|
Related party balances
|
a.
|
Due from related parties, including current and non-current portion
|
(In thousands)
|
June 30,
2013
|
March 31,
2013
|
||||||
Sheng Zhi Da Dairy Group Corporation
|
$
|
1,910
|
$
|
1,882
|
||||
Beijing Honnete Dairy Co., Ltd.
|
2
|
0
|
||||||
St. Angel (Beijing) Business Service Co. Ltd.
|
3,390
|
3,132
|
||||||
Beijing Ao Naier Feed Stuff Co., Ltd.
|
626
|
663
|
||||||
Total
|
$
|
5,928
|
$
|
5,677
|
b.
|
Due to related parties
|
(In thousands)
|
June 30,
2013
|
March 31,
2013
|
||||||
Sheng Zhi Da Dairy Group Corporation
|
$
|
929
|
$
|
1,107
|
||||
Beijing Honnete Dairy Co., Ltd.
|
483
|
495
|
||||||
Beijing Kelqin Dairy Co. Ltd.
|
0
|
6
|
||||||
Beijing St. Angel Cultural Communication Co., Ltd.
|
217
|
254
|
||||||
Total
|
$
|
1,629
|
$
|
1,862
|
B.
|
Sales to and services for related parties
|
Three Months
Ended June 30,
|
||||||||
(In thousands)
|
2013
|
2012
|
||||||
Beijing Honnete Dairy Co., Ltd.
|
$
|
2
|
$
|
328
|
||||
St. Angel (Beijing) Business Service Co., Ltd.
|
906
|
2,454
|
||||||
Beijing Ao Naier Feed Stuff Co., Ltd.
|
43
|
0
|
||||||
Total
|
$
|
951
|
$
|
2,782
|
C.
|
Purchases from related parties
|
Three Months
Ended June 30,
|
||||||||
(In thousands)
|
2013
|
2012
|
||||||
Beijing St. Angel Cultural Communication Co. Ltd.
|
$
|
121
|
$
|
170
|
||||
Beijing Kelqin Dairy Co., Ltd.
|
0
|
4
|
||||||
Total
|
$
|
121
|
$
|
174
|
5.
|
PROPERTY, PLANT AND EQUIPMENT, NET
|
(In thousands)
|
June 30,
2013
|
March 31,
2013
|
||||||
Property, plant and equipment, cost:
|
||||||||
Capital lease of building
|
$
|
5,719
|
$
|
5,637
|
||||
Buildings and renovations
|
90,936
|
84,502
|
||||||
Plant and machinery
|
83,369
|
84,559
|
||||||
Office equipment and furnishings
|
11,171
|
10,809
|
||||||
Motor vehicles
|
3,245
|
3,180
|
||||||
Others
|
984
|
918
|
||||||
Total cost
|
$
|
195,424
|
$
|
189,605
|
||||
Less: Accumulated depreciation:
|
||||||||
Capital lease of building
|
678
|
625
|
||||||
Buildings and renovations
|
17,081
|
15,750
|
||||||
Plant and machinery
|
41,772
|
40,396
|
||||||
Office equipment and furnishings
|
4,668
|
4,190
|
||||||
Motor vehicles
|
2,348
|
2,212
|
||||||
Others
|
548
|
511
|
||||||
Total accumulated depreciation
|
67,095
|
63,684
|
||||||
Construction in progress
|
1,605
|
4,200
|
||||||
Property, plant and equipment, net
|
$
|
129,934
|
$
|
130,121
|
6.
|
DEBT
|
(In thousands)
|
Year
Ending
March
31,
|
|||
2014
|
$ |
65,111
|
||
2015
|
102,514
|
|||
2016
|
33,612
|
7.
|
OTHER CURRENT LIABILITIES
|
(In thousands)
|
June 30,
2013
|
March
31, 2013
|
||||||
Accrued rebate and slotting fee
|
$
|
16,164
|
$
|
21,314
|
||||
Payroll and bonus payables
|
5,495
|
6,253
|
||||||
Accrued selling expenses
|
5,886
|
5,496
|
||||||
Accrued advertising and promotion expenses
|
7,536
|
12,034
|
||||||
Other tax payable
|
0
|
675
|
||||||
Accrued rental fee
|
1,453
|
1,461
|
||||||
Accrued interest expense
|
2,439
|
2,346
|
||||||
Others
|
3,885
|
3,209
|
||||||
Total
|
$
|
42,858
|
$
|
52,788
|
8.
|
INCOME TAXES
|
9.
|
EARNINGS (LOSS) PER SHARE
|
Three Months
Ended June 30,
|
||||||||
(In thousands except for per share data)
|
2013
|
2012
|
||||||
Net income (loss) attributable to common stockholders
|
$
|
4,775
|
$
|
(9,699
|
)
|
|||
Weighted average common stock outstanding – basic
|
57,301
|
57,301
|
||||||
Earnings (loss) per share – basic
|
$
|
0.08
|
$
|
(0.17
|
)
|
10.
|
CONTINGENCIES
|
11.
|
SEGMENT REPORTING
|
Three Months Ended June 30,
|
||||||||
(In thousands)
|
2013
|
2012
|
||||||
NET SALES TO EXTERNAL CUSTOMERS
|
||||||||
Powdered formula
|
$
|
68,079
|
$
|
50,455
|
||||
Foods
|
86
|
65
|
||||||
Nutritional ingredients and supplements
|
6,344
|
2,126
|
||||||
Other business
|
7,696
|
940
|
||||||
Net sales
|
$
|
82,205
|
$
|
53,586
|
||||
INTERSEGMENT SALES
|
||||||||
Powdered formula
|
$
|
14
|
$
|
0
|
||||
Foods
|
0
|
236
|
||||||
Nutritional ingredients and supplements
|
2,233
|
2,241
|
||||||
Other business
|
239
|
51
|
||||||
Intersegment sales
|
$
|
2,486
|
$
|
2,528
|
||||
GROSS PROFIT
|
||||||||
Powdered formula
|
$
|
36,281
|
$
|
18,433
|
||||
Foods
|
(328
|
)
|
(353
|
)
|
||||
Nutritional ingredients and supplements
|
(168
|
)
|
(1,040
|
)
|
||||
Other business
|
296
|
261
|
||||||
Gross profit
|
$
|
36,081
|
$
|
17,301
|
||||
Selling and distribution expenses
|
14,771
|
13,117
|
||||||
Advertising and promotion expenses
|
8,476
|
6,804
|
||||||
General and administrative expenses
|
6,452
|
7,857
|
||||||
Gain on disposal and liquidation of subsidiaries
|
367
|
420
|
||||||
Government subsidies
|
165
|
885
|
||||||
Income (loss) from operations
|
6,914
|
(9,172
|
)
|
|||||
Interest expense
|
3,887
|
3,556
|
||||||
Interest income
|
1,087
|
487
|
||||||
Other income (expense), net
|
741
|
(438
|
)
|
|||||
Income (loss) before income tax expense (benefit)
|
$
|
4,855
|
$
|
(12,679
|
)
|
(In thousands)
|
June 30,
2013
|
March 31,
2013
|
||||||
TOTAL ASSETS
|
||||||||
Powdered formula
|
$
|
488,567
|
$
|
491,079
|
||||
Foods
|
20,303
|
20,150
|
||||||
Nutritional ingredients and supplements
|
42,400
|
33,879
|
||||||
Other business
|
133,250
|
133,748
|
||||||
Intersegment elimination
|
(211,004
|
)
|
(202,712
|
)
|
||||
Total
|
$
|
473,516
|
$
|
476,144
|
●
|
Powdered formula segment: Powdered formula segment covers the sale of powdered infant and adult formula products. Major brands include Super, U-Smart, My Angel and Dutch Cow;
|
●
|
Foods segment: Foods segment covers the sale of prepared baby foods for babies and children under the brand of Huiliduo. In June 2013, we introduced prepared adult foods for patients with special nutritional needs after surgical operations;
|
●
|
Nutritional ingredients and supplements segment: Nutritional ingredients and supplements segment covers the production and sale of nutritional ingredients and supplements such as chondroitin sulfate to third parties, and microencapsulated Docosahexanoic Acid (“DHA”) and Arachidonic Acid (“ARA”) to powdered formula segment;
|
●
|
Other business segment: our other business includes non-core businesses such as ancillary sales of excess or unusable ingredients and materials to industrial customers.
|
Three Months
Ended June 30,
|
||||||||||||
(In thousands, except per share data)
|
2013
|
2012
|
%
Change
|
|||||||||
Net sales
|
$
|
82,205
|
$
|
53,586
|
53%
|
|||||||
- Powdered formula segment
|
68,079
|
50,455
|
35%
|
|||||||||
Cost of sales
|
46,124
|
36,285
|
27%
|
|||||||||
- Powdered formula segment
|
31,798
|
32,022
|
-1%
|
|||||||||
Gross profit
|
36,081
|
17,301
|
109%
|
|||||||||
- Powdered formula segment
|
36,281
|
18,433
|
97%
|
|||||||||
Gross Margin
|
44%
|
32%
|
||||||||||
- Powdered formula segment
|
53%
|
37%
|
||||||||||
Income (loss) from operations
|
6,914
|
(9,172
|
)
|
*
|
||||||||
Interest expense, net
|
2,800
|
3,069
|
-11%
|
|||||||||
Income (loss) before income tax expense
|
4,855
|
(12,679
|
)
|
*
|
||||||||
Income tax expense
|
79
|
(2,903
|
)
|
*
|
||||||||
- Effective tax rate
|
1.6%
|
22.9%
|
||||||||||
Net income (loss)
|
4,776
|
(9,776
|
)
|
*
|
||||||||
Net income (loss) attributable to common stockholders
|
$
|
4,775
|
$
|
(9,699
|
)
|
*
|
||||||
Weighted average common stock outstanding – basic
|
57,301
|
57,301
|
||||||||||
Earnings (loss) per share – basic
|
$
|
0.08
|
$
|
(0.17
|
)
|
*
|
Three Months
Ended June 30,
|
% Change in
|
|||||||||||||||||||
(In thousands, except percentage data)
|
2013
|
2012
|
%
Change
|
Volume
|
Price
|
|||||||||||||||
Powdered formula
|
$
|
68,079
|
$
|
50,455
|
35%
|
31%
|
3%
|
|||||||||||||
Foods
|
86
|
65
|
32%
|
|||||||||||||||||
Nutritional ingredients and supplements
|
6,344
|
2,126
|
198%
|
|||||||||||||||||
Other business
|
7,696
|
940
|
719%
|
|||||||||||||||||
Net sales
|
$
|
82,205
|
$
|
53,586
|
53%
|
●
|
Sales volume of powdered formula products for the three months ended June 30, 2013 was 5,744 tons, as compared to 4,380 tons for the same period in the previous year, due primarily to the reduced purchase by distributors in the three months ended June 30, 2012 after the retail price increase took effect on April 1, 2012.
|
●
|
The average selling price of our powdered formula products for the three months ended June 30, 2013 was $11,852 per ton, compared to $11,519 per ton for the same period in the previous year. Average selling price is calculated as net sales, after deducting sales discounts and rebates, divided by sales volume. We provided sales discounts and rebates to offset part of the marketing and promotional expenditures incurred at retail outlets. The average selling price had deteriorated after the quarter ended June 30, 2012 during fiscal 2013, but had fully recovered in the quarter ended June 30, 2013 as a result of the continued positive impacts of our Strategy.
|
Three Months
Ended June 30,
|
||||||||||||
(In thousands, except percentage data)
|
2013
|
2012
|
%
Change
|
|||||||||
Powdered formula
|
$
|
31,798
|
$
|
32,022
|
-1%
|
|||||||
Foods
|
414
|
418
|
-1%
|
|||||||||
Nutritional ingredients and supplements
|
6,512
|
3,166
|
106%
|
|||||||||
Other business
|
7,400
|
679
|
990%
|
|||||||||
Cost of sales
|
$
|
46,124
|
$
|
36,285
|
27%
|
Three Months
Ended June 30,
|
||||||||||||
(In thousands, except percentage data)
|
2013
|
2012
|
%
Change
|
|||||||||
Gross profit
|
$
|
36,081
|
$
|
17,301
|
109%
|
|||||||
- Powdered formula
|
36,281
|
18,433
|
97%
|
|||||||||
Gross margin
|
44%
|
32%
|
||||||||||
- Powdered formula
|
53%
|
37%
|
Three Months
Ended June 30,
|
||||||||||||
(In thousands, except percentage data)
|
2013
|
2012
|
%
Change
|
|||||||||
Selling and distribution expenses
|
$
|
14,771
|
$
|
13,117
|
13%
|
|||||||
Advertising and promotion expenses
|
8,476
|
6,804
|
25%
|
|||||||||
- Advertising expenses
|
493
|
2,871
|
-83%
|
|||||||||
- Promotion expenses
|
7,983
|
3,933
|
103%
|
|||||||||
General and administrative expenses
|
6,452
|
7,857
|
-18%
|
|||||||||
Gain on disposal and liquidation of subsidiaries
|
367
|
420
|
-13%
|
|||||||||
Government subsidies
|
165
|
885
|
-81%
|
Three Months
Ended June 30,
|
||||||||||||
(In thousands, except percentage data)
|
2013
|
2012
|
%
Change
|
|||||||||
Interest expense
|
$
|
3,887
|
$
|
3,556
|
9%
|
|||||||
Interest income
|
1,087
|
487
|
123%
|
·
|
The Company believes that the loss from operations for the year ended March 31, 2013 is primarily attributable to the short term effect of a substantial increase in the retail price of the Company’s powdered formula products beginning April 1, 2012 and management’s rationalization of the Company's sales channel which was initiated in September 2012 and was substantially completed by March 2013. The Company managed to reverse the trend contributing to losses incurred in first half of fiscal 2013, with breakeven results from operations in the third quarter of fiscal 2013, and income from operations in the fourth quarter of fiscal 2013 and first quarter of fiscal 2014.
|
·
|
In addition, the Company had positive cash flows from operations for the second half of fiscal 2013 of $41.8 million and for first quarter of fiscal 2014 of $3.3 million. The Company believes that its cash flows from operations will be sufficiently positive for next twelve months to satisfy its obligations when they fall due.
|
·
|
As of June 30, 2013, the Company had unused credit facility of $17.1 million which could be used when purchase of materials is initiated and the purchased inventory is used as pledge. The facility is not unconditionally committed as the bank may refuse to fund if there is material adverse change to the Company’s operations. However, for normal operational needs, it provides a backup source of liquidity.
|
·
|
In July 2013, the Company had repaid short-term bank loans of $22.8 million, had borrowed short-term bank loans of $22.3 million and long-term bank loans of $3.2 million.
|
Three Months
Ended June 30,
|
||||||||
(In thousands)
|
2013
|
2012
|
||||||
Cash flow provided by/(used in):
|
||||||||
Operating activities
|
||||||||
Net income (loss)
|
$
|
4,776
|
$
|
(9,776
|
)
|
|||
Depreciation and amortization
|
3,495
|
3,321
|
||||||
Bad debt expense
|
(413
|
)
|
922
|
|||||
Other
|
(321
|
)
|
(382
|
)
|
||||
Changes in assets and liabilities
|
(4,201
|
)
|
(36,502
|
)
|
||||
Total operating activities
|
3,336
|
(42,417
|
)
|
|||||
Investing activities
|
(3,796
|
)
|
(3,277
|
)
|
||||
Financing activities
|
1,892
|
49,128
|
||||||
Effect of foreign currency translation on cash and cash equivalents
|
452
|
(144
|
)
|
|||||
Net change in cash and cash equivalents
|
$
|
1,884
|
$
|
3,290
|
Exhibit
Number
|
Description
|
|
31.1
|
Certification of Principal Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a), promulgated under the Securities and Exchange Act of 1934, as amended
|
|
31.2
|
Certification of Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a), promulgated under the Securities and Exchange Act of 1934, as amended
|
|
32.1
|
Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Chief Executive Officer)
|
|
32.2
|
Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Chief Financial Officer)
|
|
101
|
Interactive data files pursuant to Rule 405 of Regulation S-T: (i) the Consolidated Balance Sheets—June 30, 2013 and March 31, 2013, (ii) the Consolidated Statements of Operations—Three Months Ended June 30, 2013 and 2012, (iii) the Consolidated Statements of Comprehensive Income(Loss)—Three Months Ended June 30, 2013 and 2012, (iv) the Consolidated Statements of Equity—Three Months Ended June 30, 2013 and 2012, (v) the Consolidated Statements of Cash Flows—Three Months Ended June 30, 2013 and 2012, and (vi) Notes to Consolidated Financial Statements.*
|
*
|
As provided in Rule 406T of Regulation S-T, this information is furnished and not filed for purposes of Sections 11 and 12 of the Securities Act of 1933 and Section 18 of the Securities Exchange Act of 1934.
|
SYNUTRA INTERNATIONAL, INC.
|
||||||
Date:
|
August 8, 2013
|
By:
|
/s/ Liang Zhang
|
|||
Name:
|
Liang Zhang
|
|||||
Title:
|
Chief Executive Officer and Chairman
|
By:
|
/s/ Ning Cai
|
|||||
Name:
|
Ning Cai
|
|||||
Title:
|
Chief Financial Officer
|
1.
|
I have reviewed this quarterly report on Form 10-Q of Synutra International, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date: August 8, 2013
|
|||
By:
|
/s/ Liang Zhang
|
||
Name:
|
Liang Zhang
|
||
Title:
|
Chief Executive Officer
|
I, Ning Cai, certify that:
|
1.
|
I have reviewed this quarterly report on Form 10-Q of Synutra International, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date: August 8, 2013
|
|||
By:
|
/s/ Ning Cai
|
||
Name:
|
Ning Cai
|
||
Title:
|
Chief Financial Officer
|
Date: August 8, 2013
|
|||
By:
|
/s/ Liang Zhang
|
||
Name:
|
Liang Zhang
|
||
Title:
|
Chief Executive Officer
|
Date: August 8, 2013
|
|||
By:
|
/s/ Ning Cai
|
||
Name:
|
Ning Cai
|
||
Title:
|
Chief Financial Officer
|
Contingencies
|
3 Months Ended | ||
---|---|---|---|
Jun. 30, 2013
|
|||
Contingencies [Abstract] | |||
Contingencies |
The Company is subject to legal proceedings and claims which arise in the ordinary course of business. Claims have been made against the Company from time to time. The Company intends to contest each lawsuit vigorously. The Company is not involved in any legal proceedings which it believes will have the potential for a materially adverse impact on the Company's business or financial condition, results of operations or cash flows. |
Inventories
|
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2013
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inventories [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inventories |
The Company's inventories at June 30, 2013 and March 31, 2013 are summarized as follows:
The value of goods-in-transit included in raw materials was $5.2 million and $15.9 million as of June 30, 2013 and March 31, 2013, respectively, which mainly represented the purchase of milk powder and whey protein powder from international sources.
|
Earnings (Loss) Per Share (Tables)
|
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2013
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings (Loss) Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule Of Earnings Per Share, Basic And Diluted |
|
Segment Reporting
|
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2013
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting |
The Company focuses on selling powdered formula products for infant and adult, which are supplemented by other nutritional products, such as prepared foods and certain nutritional ingredients and supplements. The activities of each segment are as follows:
Powdered Formula - Sales of powdered infant and adult formula products.
Foods - Sales of prepared foods for babies, children and adult.
Nutritional Ingredients and Supplements - Sales of nutritional ingredients and supplements such as chondroitin sulfate to external customers, and microencapsulated Docosahexanoic Acid ("DHA") and Arachidonic Acid ("ARA") to powdered formula segment.
Other business - Other business includes non-core businesses such as ancillary sales of excess or unusable ingredients and materials to industrial customers.
The Company's underlying accounting records are maintained on a legal entity basis for government and public reporting requirements. Segment disclosures are on a performance basis consistent with internal management reporting.
|
Inventories (Details) (USD $)
|
Jun. 30, 2013
|
Mar. 31, 2013
|
---|---|---|
Inventories [Abstract] | ||
Raw materials | $ 47,043,000 | $ 56,607,000 |
Work-in-progress | 19,973,000 | 17,023,000 |
Finished goods | 12,878,000 | 14,077,000 |
Total | 79,894,000 | 87,707,000 |
Goods-in-transit included in raw materials | $ 5,200,000 | $ 15,900,000 |
Basis Of Presentation (Narrative) (Details) (USD $)
|
1 Months Ended | 3 Months Ended | 6 Months Ended | 12 Months Ended | |
---|---|---|---|---|---|
Jul. 31, 2013
|
Jun. 30, 2013
|
Jun. 30, 2012
|
Mar. 31, 2013
|
Mar. 31, 2013
|
|
Basis Of Presentation [Abstract] | |||||
Current liabilities exceed current assets, amount | $ 35,900,000 | ||||
Asset liability ratio | 93.00% | ||||
Income (loss) before income tax expense | 4,855,000 | (12,679,000) | 27,000,000 | ||
Operating Income (Loss) | 6,914,000 | (9,172,000) | |||
Net cash from operations | 3,336,000 | (42,417,000) | 41,800,000 | (5,700,000) | |
Debt instrument, unused borrowing capacity | 17,100,000 | ||||
Repayment of short-term debt | 22,800,000 | 54,730,000 | 34,471,000 | ||
Proceeds from short-term debt | 22,300,000 | 42,297,000 | 76,446,000 | ||
Proceeds from long-term debt | $ 3,200,000 | $ 40,776,000 | $ 39,103,000 |
Debt (Schedule Of Maturities On Long-Term Debt) (Details) (USD $)
In Thousands, unless otherwise specified |
Jun. 30, 2013
|
---|---|
Debt [Abstract] | |
2014 | $ 65,111 |
2015 | 102,514 |
2016 | $ 33,612 |
Related Parties And Related Party Transactions (Schedule Of Purchases From Related Parties) (Details) (USD $)
In Thousands, unless otherwise specified |
3 Months Ended | |
---|---|---|
Jun. 30, 2013
|
Jun. 30, 2012
|
|
Related Party Transaction [Line Items] | ||
Purchases from related parties | $ 121 | $ 174 |
Beijing St. Angel Cultural Communication Co., Ltd. [Member]
|
||
Related Party Transaction [Line Items] | ||
Purchases from related parties | 121 | 170 |
Beijing Kelqin Dairy Co., Ltd. [Member]
|
||
Related Party Transaction [Line Items] | ||
Purchases from related parties | $ 0 | $ 4 |
Segment Reporting (Tables)
|
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2013
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule Of Segment Reporting Information By Activities Of Each Segment |
|
Consolidated Statements Of Equity (USD $)
In Thousands |
Common Stock [Member]
|
Additional Paid-In Capital [Member]
|
Retained Earnings (Accumulated Deficit) [Member]
|
Accumulated Other Comprehensive Income [Member]
|
Noncontrolling Interest [Member]
|
Total
|
---|---|---|---|---|---|---|
Balance at Mar. 31, 2012 | $ 6 | $ 135,440 | $ (71,620) | $ 32,201 | $ 1,065 | $ 97,092 |
Balance, shares at Mar. 31, 2012 | 57,301 | |||||
Net income (loss) | 0 | 0 | (9,699) | 0 | (77) | (9,776) |
Other comprehensive income, net of tax of nil | 0 | 0 | 0 | (996) | (2) | (998) |
Other | 0 | 0 | 0 | 0 | 39 | 39 |
Other, shares | 0 | |||||
Balance at Jun. 30, 2012 | 6 | 135,440 | (81,319) | 31,205 | 1,025 | 86,357 |
Balance, shares at Jun. 30, 2012 | 57,301 | |||||
Balance at Mar. 31, 2013 | 6 | 135,440 | (135,508) | 28,828 | 441 | 29,207 |
Balance, shares at Mar. 31, 2013 | 57,301 | |||||
Net income (loss) | 0 | 0 | 4,775 | 0 | 1 | 4,776 |
Other comprehensive income, net of tax of nil | 0 | 0 | 0 | 552 | 0 | 552 |
Balance at Jun. 30, 2013 | $ 6 | $ 135,440 | $ (130,733) | $ 29,380 | $ 442 | $ 34,535 |
Balance, shares at Jun. 30, 2013 | 57,301 |
Organization And Principal Activities
|
3 Months Ended |
---|---|
Jun. 30, 2013
|
|
Organization And Principal Activities [Abstract] | |
Organization And Principal Activities | 1. ORGANIZATION AND PRINCIPAL ACTIVITIES Synutra International, Inc. and its subsidiaries (hereinafter collectively referred to as the "Company" or "Synutra") are principally engaged in production, distribution and sales of dairy based nutritional products under the "Shengyuan" or "Synutra" line of brands in the People's Republic of China ("China" or "PRC"). The Company focuses on selling powdered formula products for infant and adult, which are supplemented by other nutritional products, such as prepared foods and certain nutritional ingredients and supplements. |
Related Parties And Related Party Transactions
|
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2013
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Related Parties And Related Party Transactions [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Related Parties And Related Party Transactions |
The Company had certain related party borrowings which were recorded in long-term debt due within one year. See Note 6. Except for the related party borrowings, the amount due to and due from related parties were unsecured and interest free.
In the three months ended June 30, 2013, the Company's sales to related parties mainly included feed grade whey protein powder sold to Ao Naier and powdered formula products sold to St. Angel (Beijing) Business Service. Other transactions with related parties included renting office spaces to Honnete, Ao Naier and St. Angel (Beijing) Business Service, which was immaterial. In the three months ended June 30, 2012, the Company's sales to related parties included whey protein to Honnete and powdered formula products to St. Angel (Beijing) Business Service.
In the three months ended June 30, 2013, St. Angel Cultural Communication implemented certain marketing activities for the Company. In the three months ended June 30, 2012, St. Angel Cultural Communication implemented certain marketing activities for the Company, and the Company purchased supplies for the employee canteen from Kelqin. Kelqin was sold to a third party in April 2013, and was no longer considered a related party from that date.
|
Basis Of Presentation
|
3 Months Ended | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2013
|
|||||||||||
Basis Of Presentation [Abstract] | |||||||||||
Basis Of Presentation |
The Company is responsible for the unaudited consolidated financial statements included in this document, which have been prepared in accordance with accounting principles generally accepted in the United States of America ("US GAAP") and include all normal and recurring adjustments that management of the Company considers necessary for a fair presentation of its financial position and operating results. The Company prepared these statements following the requirements of the U.S. Securities and Exchange Commission (the "SEC") for interim reporting. As permitted under those rules, the Company condensed or omitted certain footnotes or other financial information that are normally required by US GAAP for annual financial statements. These statements should be read in combination with the consolidated financial statements in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2013.
As of June 30, 2013, the Company's current liabilities exceed its current assets by $35.9 million and the Company has an asset liability ratio of 93%, which is defined as total liabilities divided by total assets. In addition, the Company suffered a loss before income tax expense of $27.0 million and incurred negative cash flows from operations of $5.7 million for the fiscal year ended March 31, 2013. However, the Company regards the going concern assumption as appropriate considering the following mitigating factors:
Based on the above factors, management believes that adequate sources of liquidity will exist to fund the Company's working capital and capital expenditure requirements, and to meet its short term debt obligations, other liabilities and commitments as they become due. Accordingly, management believes the Company will be able to realize its assets and satisfy its liabilities in the normal course of business. As a result, the accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern.
The unaudited consolidated financial statements include the financial statements of Synutra International, Inc. and its subsidiaries, its consolidated variable interest entity, Beijing Shengyuan Huimin Technology Service Co., Ltd., its subsidiaries and Heilongjiang Shengyuan Huiren Clinical Examination Co., Ltd., (Collectively the "VIEs"), in which it has a controlling financial interest. A controlling financial interest is typically determined when a company holds a majority of the voting equity interest in an entity. US GAAP provides guidance on the identification and financial reporting for entities over which control is achieved through means other than voting interests, which requires certain VIEs to be consolidated by the primary beneficiary of the entity if the equity investors in the entity do not have the characteristics of a controlling financial interest or do not have sufficient equity at risk for the entity to finance its activities without additional subordinated financial support from other parties. Through the contractual arrangements between the Company and the VIEs, the Company controls the operating activities and holds all the beneficial interests of the VIEs and has been determined to be the primary beneficiary of the VIEs. The Company has concluded that such contractual arrangements are legally enforceable. The operations associated with the consolidated VIEs are insignificant and hold deminimis assets and liabilities.
Net income or loss of a subsidiary is attributed to the Company and to the noncontrolling interests either on the basis of relative ownership interest or in accordance with contractual agreements that specify a different allocation, such as in the case of VIEs. Noncontrolling interests in subsidiaries are presented separately from the Company's equity therein.
All inter-company accounts and transactions have been eliminated in consolidation.
The operating results for interim periods are not necessarily indicative of results that may be expected for any other interim period or for the full year. |
Related Parties And Related Party Transactions (Schedule Of Due From Related Parties) (Details) (USD $)
In Thousands, unless otherwise specified |
Jun. 30, 2013
|
Mar. 31, 2013
|
---|---|---|
Related Party Transaction [Line Items] | ||
Due from related parties | $ 5,928 | $ 5,677 |
Sheng Zhi Da Dairy Group Corporation [Member]
|
||
Related Party Transaction [Line Items] | ||
Due from related parties | 1,910 | 1,882 |
Beijing Honnete Dairy Co., Ltd. [Member]
|
||
Related Party Transaction [Line Items] | ||
Due from related parties | 2 | 0 |
St. Angel (Beijing) Business Service Co., Ltd. [Member]
|
||
Related Party Transaction [Line Items] | ||
Due from related parties | 3,390 | 3,132 |
Beijing Ao Naier Feed Stuff Co., Ltd. [Member]
|
||
Related Party Transaction [Line Items] | ||
Due from related parties | $ 626 | $ 663 |